LDS/Medical Tests/Gastrin, Serum

Gastrin, Serum

Gastrin levels are used to determine whether a patient with active ulcer disease has a gastrinoma (gastrin secreting tumor). Gastrins are polypeptide hormones secreted from G cells in the gastric antrum and occasionally in the pancreas and duodenum. They stimulate acid secretion from the gastric parietal cells. There are at least three different molecular forms of the gastrin enzyme in the peripheral blood and all are biologically active. They differ only by the chain length of the N-terminal end. The largest is composed of 34 amino acids, the midsize is composed of 17 amino acids, and the smallest is composed of 14 amino acids. The test measures the sum of all three because fractionating is not clinically useful. Measurement is usually performed by RIA; polyclonal antibodies react with all three compounds. Gastrin stimulates histamine secretion by enterochromaffin-like cells in the gastric antrum; the histamine stimulates parietal cells to secrete acid. The enterochromaffin-like cells can undergo hyperplasia, sometimes leading to carcinoid tumors, which can lead to acid overproduction causing ulcers in the upper gastrointestinal tract. Gastrin values fluctuate throughout the day and are lowest in the early morning.

The most important clinical use for gastrin is to detect Zollinger-Ellison syndrome. This disease is characterized by non-beta cell tumors of the pancreas or small intestine (islet cell tumors, gastrinomas) overproducing gastrin, which leads to acid overproduction. Consequently the patient suffers from severe ulcers. Gastric carcinoids usually are associated with atrophic gastritis. Gastrinomas also may occur elsewhere in the gastrointestinal (GI) tract including the duodenum and other GI locations. Increased serum gastrin levels may also be seen in renal failure (due to decreased excretion), autoimmune diseases such as rheumatoid arthritis and liver cirrhosis.

  • Diagnosis of gastrin-secreting tumors (gastrinoma)
  • Diagnosis of Zollinger-Ellison syndrome
  • As an aid in diagnosis of chronic atrophic gastritis

Increased in:

  • Gastrinoma
  • Zollinger-Ellison syndrome with a 80 – 93% sensitivity
  • Antral G cell hyperplasia
  • Hypochlorhydria
  • Achlorhydria
  • Chronic atrophic gastritis
  • Renal failure
  • Isolated retained antrum
  • Rheumatoid arthritis
  • Cirrhosis
  • Post resection of large portions of the small bowel
  • Pernicious anemia.
  • Drugs: antacids, cimetidine, and other H2 blockers
  • Omeprazole and other proton pump inhibitors

Decreased in:

  • Antrectomy with vagotomy (removal of the pyloric antrum with the surgical severance of vagus nerve fibers)
Units: pg/mL / pmol/L
Group pg/mL pmol/L
Cord 20–290 9.5–138
0–4 days 120–183 57–87
Children 10–125 5–59
Adult 16–60 years 25–90 12–43
Adult ≥60 years 100 48
Radioimmunoassay (RIA).

Serum (SST tube).

Stability

  • Ambient:  Unacceptable
  • Refrigerated: Unacceptable
  • Frozen: 28 days

Helicobacter pylori (H. pylori) Urease test, H. pylori Antibody, Gastric and/or Duodenal Biopsy with Histology, Vitamin B12 (cobalamin), Shilling Test, Pepsinogen I and II, Secretin Challenge Test.

1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Tohoku J Exp Med. 2011;223(1):35-44. [PMID: 21222340]
  • Best Pract Res Clin Endocrinol Metab. 2004 Dec;18(4):555-68. [PMID: 15533775]
  • Clin Biochem. 1984 Apr;17(2):82-8. [PMID: 6329549]
  • N Engl J Med. 1987 Nov 5;317(19):1200-9. [PMID: 3309661]
  • Surg Oncol Clin N Am. 2006 Jul;15(3):479-96. [PMID: 16882493]
  • Minerva Med. 2005;96:187. [PMID: 16175161]
  • Jacobs DS, DeMott WR. Laboratory Test Handbook. 5th. Hudson, OH. Lexi-Comp, Inc (2001).